Lindbrook Capital, LLC Regenxbio Inc. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$12.89 - $20.82 $1,121 - $1,811	87 New	87 $1,000
Q2 2022 Aug 01, 2022	SELL	$19.35 - $35.04 $1,915 - $3,468	-99 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$24.62 - $34.31 $1,255 - $1,749	-51 Reduced 34.0%	99 $3,000
Q4 2021 Jan 18, 2022	BUY	$30.19 - $40.28 $1,932 - $2,577	64 Added 74.42%	150 $5,000
Q3 2021 Nov 05, 2021	BUY	$29.09 - $45.68 $1,454 - $2,284	50 Added 138.89%	86 $4,000
Q4 2020 Jan 27, 2021	BUY	$26.52 - $49.35 $954 - $1,776	36 New	36 $2,000
Q1 2019 Apr 23, 2019	SELL	$40.82 - $62.45 $8,164 - $12,490	-200 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$39.11 - $75.15 $7,822 - $15,030	200 New	200 $8,000

192

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $319M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.